N2-Trityl Olmesartan Acid CAS 752179-89-8 Purity >98.0% (HPLC) Olmesartan Medoxomil Intermediate Factory
Ruifu Chemical Supply Olmesartan Medoxomil Intermediates With High Quality:
4,5-Dimethyl-1,3-Dioxol-2-Kotahi (DMDO) CAS 37830-90-3
4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One (DMDO-Cl) CAS 80841-78-7
Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylate CAS 144689-93-0
Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1
Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Trityl Olmesartan Acid CAS 761404-85-7
N2-Trityl Olmesartan Waikawa CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Ingoa matū | N2-Trityl Olmesartan Waikawa |
Nga kupu taurite | Trityl Olmesartan waikawa (N2);Olmesartan N2-Trityl poke;4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl ]mewaro]-1H-Imidazole-5-Carboxylic Acid;4-(2-Hydroxypropan-2-yl)-2-Propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl) methyl) -1H-Imidazole-5-Wakawa Waikawa |
Tau CAS | 752179-89-8 |
Tau CAT | RF-PI1876 |
Tūnga Taonga | I roto i te Stock, Production Tauine Up ki Taranata |
Tātai rāpoi | C43H40N6O3 |
Taumaha rāpoi | 688.82 |
Waitohu | Ruifu Chemical |
Tūemi | Whakatakotoranga |
Te ahua | Ma ki te Paura-White |
Te Maama / Tikanga Tatauria | >98.0% (HPLC) |
Ngaronga i te whakamaroke | <1.00% |
Te toenga i runga i te mura | <0.50% |
Te poke kotahi | <1.00% |
Nga poke katoa | <2.00% |
Konga Taamaha (hei Pb) | <20ppm |
Paerewa Whakamatau | Paerewa hinonga |
Whakamahinga | Takawaenga o Olmesartan Medoxomil (CAS: 144689-63-4) |
Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Kaata Drum, kia rite ranei ki te hiahia a te kaihoko
Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku
Ko te N2-Trityl Olmesartan Acid (CAS: 752179-89-8) he takawaenga i roto i te whakahiato o Olmesartan Medoxomil (CAS: 144689-63-4) e pa ana.Ko te Olmesartan Medoxomil he angiotensin II receptor antagonist kua whakamahia mo te maimoatanga o te toto toto tiketike.Ko te Olmesartan Medoxomil he prodrug o Olmesartan, he angiotensin II momo 1 receptor (AT1) aukati e aukati ana i nga urupare ture kino mo te renin secretion, te whakaheke i te hunanga o te aldosterone me te heke o te aukati vascular peripheral (vasodilation).Ko tenei puhui e whakaatu ana i nga mahi antihypertensive, cardioprotective, vasodilatory, me nga mahi anti-inflammatory.Ko te Olmesartan Medoxomil ka taea te whakamahi takitahi, te whakakotahi ranei me etahi atu raau taero antihypertensive.I roto i nga rangahau haumanu whakatairite i nga turoro me te whakaheke toto nui, ka whakahekehia e Olmesartan te pehanga toto diastolic noho ki runga ake i a Losartan, Valdesartan me Ibesartan, ko te whakaheke i te pehanga toto systolic he rite mo nga maimoatanga katoa.